New Reports Have Been Recently Added to Healthcare Catalogue
10 Mar 2022 • by Natalie Aster
LONDON – The Market Publishers’ collection of topical research reports covering various sectors of the healthcare industry has been recently enlarged with a great number of new research reports from our research partners. Here are only some of the in-demand research studies recently uploaded to the healthcare catalogue at MarketPublishers.com:
The global market for RNAi therapeutics is forecast to exhibit robust growth at a CAGR of slightly over 10% in the next 5 years, propelled by the increasing use in oncology pharmaceuticals, rising incidence of infectious diseases and neurodegenerative disorders, growing geriatric population, and an upturn in collaborations and associated deals in RNAi therapeutics field. However, several challenges may hamper the market growth to some extent, for instance, certain complexities associated with the drug delivery of RNAi therapeutics, high development costs of RNA interference-based therapeutics, and stringent regulatory norms. By 2026, the value of the global RNAi therapeutics market is poised to reach USD 1.15 billion…
Interventional Pulmonology Market
The value of the global interventional pulmonology market is expected to come to USD 4.68 billion in 2026, demonstrating growth at a 5.84% CAGR in the next 5 years. Factors such as the increasing incidence of lung cancer, growing CO2 emissions, ongoing expansion of the medical devices industry, soaring COPD mortality rate, growing aging population, and enhancing public awareness are poised to act as the key market growth drivers during the forecast period. Robotic bronchoscopy is emerging as a game-changer in the interventional pulmonology market. Geographically, the Chinese interventional pulmonology market is anticipated to exhibit the highest growth rates through 2026…
During the past 50 years, the Nuclear Medicine field has demonstrated a strong link between investments in chemistry and the development of radionuclide and radio-labeled compounds which have impacted the healthcare practice. The world’s nuclear medicine market is projected to increase at a mid-single-digit CAGR during 2022-2030 and is expected to go beyond USD 11.36 billion in value terms by the end of the forecast period. The increasing number of radioisotopes applications, rising public awareness, growing usage of SPECT/CT and PET/CT imaging scans, abundant availability of radiopharmaceuticals, ongoing advancements in imaging technologies and alpha therapy-based targeted cancer treatment will likely act as the major growth engines of the nuclear medicine market growth. Besides, the mounting demand from emerging markets, rising production of radiopharmaceuticals from cyclotrons, and an upturn in the replacement of old/traditional equipment will also create lucrative growth opportunities for the nuclear medicine market…
The global gynecology drugs market is projected to increase at a CAGR of 8.64% in the next 5 years, propelled by significant changes in women's lifestyles, the rising prevalence of various gynecological disorders, increasing penetration of online sales channels, and high-end investments by the market players to procure effective gynecology drugs. In value terms, this market is poised to increase from over USD 14.1 billion in 2021 to cross USD 21.3 billion in the year 2027. Retail pharmacies form the leading distribution channel for gynecology drugs, capturing a market share of around 48%, and are expected to maintain their dominance throughout the forecast period…
The world’s telemedicine market is expected to come to the value of USD 380.3 billion by the year 2030, expanding at an impressive CAGR of 19.5% during 2022-2030. The major market growth engines include the increasing prevalence of chronic conditions, growing geriatric population, soaring interest in telehealth, and escalating demand for reduction in care costs. Furthermore, the COVID-19 pandemic has given a boost to the global telemedicine market growth. The teleradiology segment commanded the major market revenue share in 2021, whilst the telepsychiatry segment is estimated to grow at the highest CAGR from 2022 to 2030…
A full collection of Market Publishers’ research studies featuring different sectors of the healthcare market is available in this catalogue.
Analytics & News
